-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 16, Fu'an Pharmaceutical issued an announcement stating that its wholly-owned subsidiary, Chu Pharmaceutical, had recently received a drug registration certificate for Esomeprazole Sodium for Injection approved and issued by the National Medical Products Administration
Esomeprazole sodium for injection is suitable for replacement therapy of gastroesophageal reflux disease when oral therapy is not applicable, for low-risk patients with acute gastric or duodenal ulcer bleeding where oral therapy is not applicable, and for reducing The risk of rebleeding after endoscopic treatment of adult gastric and duodenal ulcer bleeding, prevention of stress ulcer bleeding in critically ill patients
Up to now, including Zhichu Pharmaceutical, a total of 15 manufacturers of this product have passed the consistency evaluation or deemed to have passed the consistency evaluation